Designer Liposomic Nanocarriers Are Effective Biofilm Eradicators

Drug delivery via nanovehicles is successfully employed in several clinical settings, yet bacterial infections, forming microbial communities in the form of biofilms, present a strong challenge to therapeutic treatment due to resistance to conventional antimicrobial therapies. Liposomes can provide...

Full description

Saved in:
Bibliographic Details
Published in:ACS nano 2022-10, Vol.16 (10), p.15792-15804
Main Authors: Kluzek, Monika, Oppenheimer-Shaanan, Yaara, Dadosh, Tali, Morandi, Mattia I., Avinoam, Ori, Raanan, Calanit, Goldsmith, Moshe, Goldberg, Ronit, Klein, Jacob
Format: Article
Language:English
Subjects:
Anti-Bacterial Agents - pharmacology
Anti-Infective Agents - pharmacology
Biofilms
Ions
Lipopolysaccharides - pharmacology
Liposomes - pharmacology
Microbial Sensitivity Tests
Phosphorylcholine
Pseudomonas aeruginosa
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!